Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01HL089637 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The use of sugar and starch-like foods for energy (carbohydrate metabolism) changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the carbohydrate metabolism of people who have a relative with type 2 diabetes (parent, sibling, or grandparent). This study is being done to test the hypothesis that individual differences in habitual sleep duration may be related to differences in the carbohydrate metabolism of people who have a history of type 2 diabetes in their family.
On two consecutive inpatient days, the participants in this study will undergo two different tests. The first test will determine how much insulin can their body produce in response to an intravenous glucose infusion over a period of several hours. The second test will determine how effective is the action of the sugar-processing hormone, insulin, in their body when it is infused intravenously together with glucose over a period of several hours.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Reduced sleep | Habitual sleep duration of less than 6 hours per night on most days of the week and total sleep of less than 43 hours per week. | ||
| Reference sleep | Habitual sleep duration between 7 and 8.5 hours per night on most days of the week and total sleep of at least 53 hours per week. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Total body insulin sensitivity | at the end of a 4-hour hyperinsulinemic clamp |
| Measure | Description | Time Frame |
|---|---|---|
| First and second phase insulin secretion | during a 3-hour hyperglycemic clamp | |
| Endogenous glucose production | before and during a 4-hour hyperinsulinemic clamp | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Healthy non-obese community-living men and women with a parent, sibling or grandparent who has type 2 diabetes
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Plamen D Penev, MD, PhD | University of Chicago | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 | United States |
Not provided
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Glycerol turnover and free fatty acid concentration |
| before and during a 4-hour hyperinsulinemic clamp |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |